These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25847319)

  • 1. Patients with psoriasis have insufficient knowledge of their risk of atherothrombotic disease and metabolic syndrome.
    Skiveren J; Philipsen P; Therming G
    Clin Exp Dermatol; 2015 Aug; 40(6):600-4. PubMed ID: 25847319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors.
    Gisondi P; Girolomoni G
    Semin Thromb Hemost; 2009 Apr; 35(3):313-24. PubMed ID: 19452407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Psoriasis and atherothrombotic disease].
    Ahlehoff O; Gislason GH; Skov L; Hansen PR
    Ugeskr Laeger; 2010 Jun; 172(26):1983-6. PubMed ID: 20654288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.
    Miele L; Vallone S; Cefalo C; La Torre G; Di Stasi C; Vecchio FM; D'Agostino M; Gabrieli ML; Vero V; Biolato M; Pompili M; Gasbarrini G; Rapaccini G; Amerio P; De Simone C; Grieco A
    J Hepatol; 2009 Oct; 51(4):778-86. PubMed ID: 19664838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: a nationwide cohort study.
    Chen YJ; Chang YT; Shen JL; Chen TT; Wang CB; Chen CM; Wu CY
    Arthritis Rheum; 2012 Jun; 64(6):1879-87. PubMed ID: 22161801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with drug survival of methotrexate and acitretin in patients with psoriasis.
    Shalom G; Zisman D; Harman-Boehm I; Biterman H; Greenberg-Dotan S; Polishchuk I; Moser H; Freud T; Feldhamer I; Cohen AD
    Acta Derm Venereol; 2015 Nov; 95(8):973-7. PubMed ID: 25950855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis.
    Tobin AM; Veale DJ; Fitzgerald O; Rogers S; Collins P; O'Shea D; Kirby B
    J Rheumatol; 2010 Jul; 37(7):1386-94. PubMed ID: 20472927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriasis as initiator or amplifier of the systemic inflammatory march: impact on development of severe vascular events and implications for treatment strategy.
    Su YS; Yu HS; Li WC; Ko YC; Chen GS; Wu CS; Lu YW; Yang YH; Lan CC
    J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):876-83. PubMed ID: 22702656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical aspects and comorbidities of psoriasis.
    Ayala F; Ayala F
    J Rheumatol Suppl; 2009 Aug; 83():19-20. PubMed ID: 19661531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidities in patients with psoriasis.
    Gottlieb AB; Dann F
    Am J Med; 2009 Dec; 122(12):1150.e1-9. PubMed ID: 19958894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic comorbidities and psoriasis.
    Gisondi P; Ferrazzi A; Girolomoni G
    Acta Dermatovenerol Croat; 2010; 18(4):297-304. PubMed ID: 21251450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity.
    Eder L; Jayakar J; Pollock R; Pellett F; Thavaneswaran A; Chandran V; Rosen CF; Gladman DD
    Ann Rheum Dis; 2013 Dec; 72(12):1956-61. PubMed ID: 23243196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of risk factors for body weight increment in psoriatic patients on infliximab: a multicentre, cross-sectional study.
    Mahé E; Reguiai Z; Barthelemy H; Quiles-Tsimaratos N; Chaby G; Girard C; Estève E; Maccari F; Descamps V; Schmutz JL; Begon E; Bravard P; Maillard H; Boyé T; Beauchet A; Sigal ML;
    J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):151-9. PubMed ID: 23279264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriasis and the metabolic syndrome.
    Alsufyani MA; Golant AK; Lebwohl M
    Dermatol Ther; 2010; 23(2):137-43. PubMed ID: 20415820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abdominal obesity, waist circumference and cardio-metabolic risk: awareness among primary care physicians, the general population and patients at risk--the Shape of the Nations survey.
    Smith SC; Haslam D
    Curr Med Res Opin; 2007 Jan; 23(1):29-47. PubMed ID: 17261236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of cardio-metabolic risk profile in patients with psoriasis.
    Karoli R; Fatima J; Shukla V; Dhillon KS; Khanduri S; Maini S; Chandra A
    J Assoc Physicians India; 2013 Nov; 61(11):798-803. PubMed ID: 24974491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome.
    Chen YJ; Wu CY; Shen JL; Chu SY; Chen CK; Chang YT; Chen CM
    Arch Dermatol; 2008 Dec; 144(12):1571-5. PubMed ID: 19075139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical profile, morbidity, and outcome of adult-onset generalized pustular psoriasis: analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia.
    Choon SE; Lai NM; Mohammad NA; Nanu NM; Tey KE; Chew SF
    Int J Dermatol; 2014 Jun; 53(6):676-84. PubMed ID: 23967807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study.
    Gisondi P; Tessari G; Conti A; Piaserico S; Schianchi S; Peserico A; Giannetti A; Girolomoni G
    Br J Dermatol; 2007 Jul; 157(1):68-73. PubMed ID: 17553036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis and the metabolic syndrome.
    Cohen AD; Gilutz H; Henkin Y; Zahger D; Shapiro J; Bonneh DY; Vardy DA
    Acta Derm Venereol; 2007; 87(6):506-9. PubMed ID: 17989888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.